Articles
QIAGEN’s role in advancing companion diagnostics for precision medicine
In the evolving landscape of healthcare, precision medicine has emerged as a game-changer, promising tailored treatments and improved patient outcomes. At the forefront of this revolution is QIAGEN, a global leader in Sample to Insight solutions, making significant strides...
Articles
Child-resistant packaging: navigating the delicate balance between security and inclusion
Within the highly regulated pharmaceutical industry, patient safety stands as an unwavering principle. Packaging design, in this context, assumes a critical role in safeguarding the well-being of individuals. Child-resistant closures, in particular, serve as a cornerstone in preventing accidental...
Articles
Get Ready, Pharma: Drug Supply Chain Security Act (DSCSA) Enforcement Is At Hand
More than 10 years ago, Congress passed a law designed to protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. Up until now, it has never been fully enforced because drug manufacturers and...
Articles
The cell and gene therapy revolution: Milestones, mindsets and the path forward
The evolving landscape of cell and gene therapies (C>s) holds transformative potential for the future of medicine. From early experimental trials to groundbreaking FDA approvals, the journey of C>s has been marked by rapid advancements and significant hurdles. In...
Articles
How FastIns Modular Cleanroom Improve Pharmaceuticals in AI Era
When it comes to the manufacturing of drugs, particularly culture of cells, a high-level of clean and sterile environment is required with temperature, humidity and differential pressure controlled to certain ranges. Typically, traditional clean rooms lack the flexibility and...
Articles
Accelerating Towards Net Zero: Transforming The Pharmaceutical Supply Chain
The pharmaceutical industry is making remarkable progress in its quest for decarbonisation, with emissions already on a significant decline. Yet, the journey to Net Zero remains fraught with challenges, particularly in curbing Scope 3 emissions within the workplace. Now...
Articles
Preparing for the revisions to the EU’s pharmaceutical legislation – what we know now
The European Parliament recently introduced compromise amendments to the revised EU pharmaceutical legislation introduced in April 2023, and they attempt to address some of the concerns of the pharmaceutical industry and, at the same time, promote innovation by small-...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.